FDA approves Gilotrif (afatinib) as new oral treatment option for patients with squamous cell carcinoma of the lung

Source Link:

http://www.prnewswire.com/news-releases/fda-approves-gilotrif-afatinib-as-new-oral-treatment-option-for-patients-with-squamous-cell-carcinoma-of-the-lung-300252403.html